Saudi Arabia's Pharma Market Is 'Open For Business'
This article was originally published in The Pink Sheet Daily
Executive Summary
Growing market is also a gateway to the Gulf region, and Saudi regulators are developing an abridged review process for some drugs already reviewed by agencies such as FDA or EMA.